Mylan

Mylan, now part of the global healthcare company Viatris, gained notoriety with a hefty price increase for the epinephrine auto-injector EpiPen. The outrage over the 400% price hike of the anaphylaxis drug was later followed by another controversy, a $465 million settlement with the Justice Department for overbilling Medicaid. Here’s a roundup of STAT coverage.